Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) Biyan Nathanael HarapanHyeon Joo Yoo Review Open access 23 January 2021 Pages: 3059 - 3071
SARS-CoV-2 infection in patients with primary central nervous system lymphoma Alice LaurengeRenata UrsuMehdi Touat Original Communication 02 January 2021 Pages: 3072 - 3080
COVID-19 in children with neuromuscular disorders Daniel Natera-de BenitoSergio Aguilera-AlbesaNeuromuscular Working Group of Spanish Pediatric Neurology Society Original Communication 02 January 2021 Pages: 3081 - 3085
Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up Vardan NersesjanMoshgan AmiriDaniel Kondziella Original Communication Open access 13 January 2021 Pages: 3086 - 3104
Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data R. BeyroutiJ. G. BestD. J. Werring Original Communication Open access 05 February 2021 Pages: 3105 - 3115
Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms V. A. Blanco-PalmeroF. J. Azcárate-DíazJ. González de la Aleja Original Communication 19 February 2021 Pages: 3116 - 3124
Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19 Ulrich Hofstadt-van OySlobodan StankovicUlrich Cleff Short Commentary 04 February 2021 Pages: 3125 - 3128
COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy Eveline Van LooyLen VeenkerHarald De Cauwer Letter to the Editors 19 February 2021 Pages: 3129 - 3131
COVID-19 in multiple sclerosis patients treated with dimethyl fumarate Fioravante CaponeElisabetta FerraroVincenzo Di Lazzaro Letter to the Editors 20 February 2021 Pages: 3132 - 3134
Levodopa challenge test: indications, protocol, and guide Gerard SaranzaAnthony E. Lang Review 24 April 2020 Pages: 3135 - 3143
Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature Elisabetta SarassoFederica AgostaMassimo Filippi Review 06 May 2020 Pages: 3144 - 3179
Expansion of the dimensions in the current management of acute ischemic stroke Preeti MalikArsalan AnwarUrvish Patel Review 20 May 2020 Pages: 3185 - 3202
When does postural instability appear in monogenic parkinsonisms? An individual-patient meta-analysis Luca MarsiliJoaquin A. VizcarraAlberto J. Espay Review 20 May 2020 Pages: 3203 - 3211
Neurofilaments in progressive multiple sclerosis: a systematic review Thomas WilliamsHenrik ZetterbergJeremy Chataway Review Open access 23 May 2020 Pages: 3212 - 3222
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression Luca ProsperiniValentina TomassiniClaudio Marcello Solaro Review 23 May 2020 Pages: 3223 - 3237
Association between Helicobacter Pylori infection and stroke: a meta-analysis of 273,135 patients Mohamed Fahmy DoheimAhmad Amr AltaweelAmeer E. Hassan Review 23 May 2020 Pages: 3238 - 3248
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management Simona ToscanoSalvatore Lo FermoMario Zappia Review 27 May 2020 Pages: 3249 - 3268
Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment Lumei KangYuyang TianHongping Chen Review 30 May 2020 Pages: 3269 - 3282
5-Year health-related quality of life outcome in patients with idiopathic normal pressure hydrocephalus A. JunkkariH. SintonenV. Leinonen Original Communication Open access 02 March 2021 Pages: 3283 - 3293
Cerebrospinal fluid analysis in Guillain–Barré syndrome: value of albumin quotients Jakob RathGudrun ZulehnerFritz Zimprich Original Communication Open access 02 March 2021 Pages: 3294 - 3300
Transient global amnesia does not increase the risk of subsequent ischemic stroke: a propensity score-matched analysis Aayushi GargKaustubh LimayeEnrique C. Leira Original Communication 02 March 2021 Pages: 3301 - 3306
Magnetic resonance metrics to evaluate the effect of therapy in amyotrophic lateral sclerosis: the experience with edaravone Eugenio DistasoGiammarco MilellaIsabella Laura Simone Original Communication Open access 02 March 2021 Pages: 3307 - 3315
The levels of the serine protease HTRA1 in cerebrospinal fluid correlate with progression and disability in multiple sclerosis Simone HjæresenTobias SejbaekÅsa Fex Svenningsen Original Communication 04 March 2021 Pages: 3316 - 3324
Diagnostic yield of cerebrospinal fluid analysis in status epilepticus: an 8-year cohort study Tolga D. DittrichSira M. BaumannRaoul Sutter Original Communication Open access 05 March 2021 Pages: 3325 - 3336
Biallelic RFC1-expansion in a French multicentric sporadic ataxia cohort Solveig MontautNadège DiedhiouChristine Tranchant Original Communication 05 March 2021 Pages: 3337 - 3343
Effect of leuprorelin in bulbar function of spinal and bulbar muscular atrophy patients: observational study for 1 year Min-Gu KangDae-Won GwakJin-Sung Park Original Communication 06 March 2021 Pages: 3344 - 3351
Late-onset MS is associated with an increased rate of reaching disability milestones Mads Albrecht AndersenMathias Due BuronMelinda Magyari Original Communication 07 March 2021 Pages: 3352 - 3360
Prognostic models for amyotrophic lateral sclerosis: a systematic review Lu XuBingjie HeShengfeng Wang Original Communication 10 March 2021 Pages: 3361 - 3370
Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders Ana MarquesDaniel RoquetSimon J. G. Lewis Original Communication 11 March 2021 Pages: 3371 - 3380
New pathogenic variants in COQ4 cause ataxia and neurodevelopmental disorder without detectable CoQ10 deficiency in muscle or skin fibroblasts Serena MeroLeonardo SalviatiMaria Marchese Original Communication 11 March 2021 Pages: 3381 - 3389
Eye movement alterations in presymptomatic C9orf72 expansion gene carriers Anna BehlerAntje KnehrJan Kassubek Original Communication Open access 11 March 2021 Pages: 3390 - 3399
Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes Andrea Horta-BarbaJavier PagonabarragaJaime Kulisevsky Original Communication 11 March 2021 Pages: 3400 - 3408
Diffusion tensor imaging analysis in three progressive supranuclear palsy variants Jennifer L. WhitwellNirubol TosakulwongKeith A. Josephs Original Communication 12 March 2021 Pages: 3409 - 3420
Fall prediction in neurological gait disorders: differential contributions from clinical assessment, gait analysis, and daily-life mobility monitoring Roman SchnieppAnna HuppertMax Wuehr Original Communication Open access 13 March 2021 Pages: 3421 - 3434
Sympathetic and sensory nerve fiber function in multiple system atrophy and idiopathic Parkinson’s disease Heidrun H. KrämerCora RebhornFrank Birklein Original Communication Open access 13 March 2021 Pages: 3435 - 3443
Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson’s disease Mattia SicilianoLugi TrojanoAlessandro Tessitore Original Communication Open access 15 March 2021 Pages: 3444 - 3455
The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients Roderick P. P. W. M. MaasSven KillaarsDennis J. L. G. Schutter Original Communication Open access 20 March 2021 Pages: 3456 - 3466
Diagnostic value of video-oculography in progressive supranuclear palsy: a controlled study in 100 patients Jessica WunderlichAnna BehlerJan Kassubek Original Communication Open access 21 March 2021 Pages: 3467 - 3475
A solution to PET brain motion artefact Kevin M. BradleyTimothy W. DellerDaniel R. McGowan Letter to the Editors 06 June 2021 Pages: 3476 - 3477
Correction to: A solution to PET brain motion artefact Kevin M. BradleyTimothy W. DellerDaniel R. McGowan Correction 14 June 2021 Pages: 3478 - 3479
Cerebrovascular manifestations in hematological diseases: an update José M. FerroJoana Infante Neurological Update Open access 13 February 2021 Pages: 3480 - 3492
Huntington’s disease: lessons from prion disorders Melanie AlpaughFrancesca Cicchetti Neurological Update 24 February 2021 Pages: 3493 - 3504
Medication-overuse headache: causes, consequences and management Thomas H. MasseyNeil P. Robertson Journal club Open access 05 August 2021 Pages: 3505 - 3507
Siegmund Erben (1863–1942) Lazaros C. Triarhou Pioneers in Neurology 18 November 2020 Pages: 3508 - 3509
Jakub Rothfeld-Rostowski (1884–1971) Jarosław SakAntoni NiedzielskiMagdalena Suchodolska Pioneers in Neurology 03 January 2021 Pages: 3510 - 3511
William Gordon Lennox (1884–1960) Mattia RossoDuong ChuJonathan D. Santoro Pioneers in Neurology 08 January 2021 Pages: 3512 - 3513
Bernhard Dattner (1887–1952) Lazaros C. Triarhou Pioneers in Neurology 30 January 2021 Pages: 3514 - 3516